Largest-ever health imaging study to scan 100,000 people

Researchers in the United Kingdom have launched a study that aims to scan the brains and internal organs of approximately 100,000 British patients over the next six to eight years in the largest health imaging study ever conducted.

Launched by nonprofit biological data repository UK Biobank, the landmark study could help medical scientists better understand and treat myriad diseases—including heart disease, cancer and dementia—by creating the world's largest imaging database.

“One of the crucial questions we can start to answer is, what happens in the brain years before dementia, stroke or other disorders are diagnosed? Can we understand it and find new ways to treat or prevent the onset?” said Professor Paul Matthews, chairman of the study’s expert working group, in a press release. “Researchers can now test ideas quickly, armed with no more than a good idea, appropriate software and access to the necessary computational resource.” 

Data from the study—which will utilize MRI, ultrasound and dual-energy x-ray imaging—will be accessible to researchers who are registered with Biobank, with existing data already being studied by nearly 3,000 British and international scientists.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.